TriSalus Life Sciences(TLSI) - 2025 Q4 - Annual Results
Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Date of Report (Date of earliest event reported): January 12, 2026 TRISALUS LIFE SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 001-39813 85-3009869 (Commission (State or other jurisdiction of incorporation or organization) 6272 W 91st Ave, Westminster, Colorado 80031 (Address of principal executive office) (Zip ...